Cargando…

Using cost-effectiveness analyses to inform policy: the case of antiretroviral therapy in Thailand

BACKGROUND: Much emphasis is put on providing evidence to assist policymakers in priority setting and investment decisions. Assessing the cost-effectiveness of interventions is one technique used by policymakers in their decisions around the allocation of scarce resources. However, even where such e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tantivess, Sripen, Walt, Gill
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779364/ https://www.ncbi.nlm.nih.gov/pubmed/17196110 http://dx.doi.org/10.1186/1478-7547-4-21

Ejemplares similares

Utilisation of evidence from Thailand’s National Health Examination Survey in policy development: finding the weakest link
por: Tantivess, Sripen, et al.
Publicado: (2019)

Lessons drawn from research utilization in the maternal iodine supplementation policy development in Thailand
por: Tonmukayakul, Utsana, et al.
Publicado: (2012)

Advanced health biotechnologies in Thailand: redefining policy directions
por: Velasco, Román Pérez, et al.
Publicado: (2013)

Government use licenses in Thailand: an assessment of the health and economic impacts
por: Yamabhai, Inthira, et al.
Publicado: (2011)

Multi-criteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand
por: Youngkong, Sitaporn, et al.
Publicado: (2012)

What criteria do decision makers in Thailand use to set priorities for vaccine introduction?
por: Pooripussarakul, Siriporn, et al.
Publicado: (2016)

Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand
por: Yothasamut, Jomkwan, et al.
Publicado: (2010)

Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment
por: Youngkong, Sitaporn, et al.
Publicado: (2010)

The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh
por: Teerawattananon, Yot, et al.
Publicado: (2016)

Scaling up health policies and services in low- and middle-income settings
por: Hanson, Kara, et al.
Publicado: (2010)

Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE
por: Tantivess, Sripen, et al.
Publicado: (2017)

Development of a Health Screening Package Under the Universal Health Coverage: The Role of Health Technology Assessment
por: Teerawattananon, Yot, et al.
Publicado: (2016)

Cost-Effectiveness of Antiretroviral Therapy for Prevention
por: Kahn, James G, et al.
Publicado: (2011)

Cost-effectiveness analysis of ‘test and treat’ policy for antiretroviral therapy among heterosexual HIV population in India
por: Singh, Malkeet, et al.
Publicado: (2022)

How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?
por: Teerawattananon, Yot, et al.
Publicado: (2016)

Maternal and child health voucher scheme in Myanmar: a review of early stage implementation
por: Pilasant, Songyot, et al.
Publicado: (2016)

Selecting topic areas for developing quality standards in a resource-limited setting
por: Khampang, Roongnapa, et al.
Publicado: (2019)

What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria
por: Ruiz, Francis J., et al.
Publicado: (2023)

Cost-effectiveness analysis of the national decentralization policy of antiretroviral treatment programme in Zambia
por: Miyano, Shinsuke, et al.
Publicado: (2017)

Is Antiretroviral Therapy Cost-Effective in South Africa?
por: Braithwaite, R. Scott, et al.
Publicado: (2006)

The cost of antiretroviral therapy in Haiti
por: Koenig, Serena P, et al.
Publicado: (2008)

Improving mental health policy in the case of schizophrenia in Thailand: evidence-based information for efficient solutions
por: Phanthunane, Pudtan, et al.
Publicado: (2012)

Systematic Review of Economic Evaluations of Preparedness Strategies and Interventions against Influenza Pandemics
por: Pérez Velasco, Román, et al.
Publicado: (2012)

Cost–Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand
por: Phisalprapa, Pochamana, et al.
Publicado: (2023)

Cost-Effectiveness of Early Infant HIV Diagnosis of HIV-Exposed Infants and Immediate Antiretroviral Therapy in HIV-Infected Children under 24 Months in Thailand
por: Collins, Intira Jeannie, et al.
Publicado: (2014)

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand
por: Manosuthi, Weerawat, et al.
Publicado: (2015)

Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand
por: Sruamsiri, Rosarin, et al.
Publicado: (2015)

Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa
por: Badri, Motasim, et al.
Publicado: (2006)

Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand
por: Permsuwan, Unchalee, et al.
Publicado: (2020)

Cost Effectiveness and Budget Impact Analyses of Influenza Vaccination for Prisoners in Thailand: An Application of System Dynamic Modelling
por: Suphanchaimat, Rapeepong, et al.
Publicado: (2020)

Cost-Effectiveness and Cost–Utility Analyses in Thailand of Continuous Intrathecal Morphine Infusion Compared with Conventional Therapy in Cancer Pain: A 10-year Multicenter Retrospective Study
por: Thepsuwan, Arpawan, et al.
Publicado: (2023)

Access to antiretroviral therapy among HIV/AIDS patients in Chiang Mai province, Thailand
por: Himakalasa, Woraluck, et al.
Publicado: (2013)

Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings
por: Phillips, Andrew, et al.
Publicado: (2014)

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit package
por: Anothaisintawee, Thunyarat, et al.
Publicado: (2012)

Informal Care Costs According to Age and Proximity to Death to Support Cost-Effectiveness Analyses
por: de Groot, Saskia, et al.
Publicado: (2023)

Independent Effects of HIV and Antiretroviral Therapy on the Oral Microbiome Identified by Multivariate Analyses
por: Beall, Clifford J., et al.
Publicado: (2023)

A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control
por: Alfaro-Murillo, Jorge A., et al.
Publicado: (2016)

Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses
por: Welton, Nicky J., et al.
Publicado: (2015)

Correction: Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings
Publicado: (2014)

Dependency and health utilities in stroke: Data to inform cost-effectiveness analyses
por: Ali, Myzoon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9mv4fdohsicpkg0sonajo638o7